Evgeny Zaytsev, M.D., Ph.D., M.B.A. Chairman of the Board
Evgeny Zaytsev established InteKrin (Russia) in 2012 and served its President and CEO until 2013. Evgeny is an entrepreneur and venture capitalist with more than 13 years of venture capital experience at RMI Partners, Helix Ventures and Asset Management Company. While at Asset Management Company, he was one of the early investors in InteKrin Therapeutics.
Evgeny has been one of the key executives of the Medico-Ecological Institute, a research institute established in Russia in 1993 to study the health and environmental effects of the Soviet Union’s nuclear testing program. An expert in physiology and radiation biology, he was chief scientific officer from 1994 to 2000 and during his tenure the institute became an internationally recognized research center. He is the author or co-author of 70 scientific and business publications, including six books on radiation and cancer epidemiology. From 1991 to 2000, he was also an assistant professor in physiology at the Altai State Medical University in Barnaul, Siberia.
He received his M.D. (cum laude) in 1991 and his Ph.D. in physiology in 1993, both from the Altai State Medical University. He earned his M.B.A. from the Stanford Graduate School of Business in 2002. He is currently a director of several private life sciences companies, as well as an advisor to a number of professional organizations.
Varvara Melikhova Director, Development (Russia)
Dr. Melikhova joined ZAO InteKrin as Director, Development in early 2013 and manages InteKrin’s effort to develop INT-131 in the territory of Russia and CIS.
Most recently, Varvara was Market Access Manager for UCB Pharma in Russia. Prior to that, she held similar positions for Merck Serono and Johnson & Johnson. During this time, she led several federal and regional projects aiming to give patients access to innovative treatments and create fair conditions for state purchases of these products.
Varvara holds an M.Sc. Degree in Cell Biology from Moscow State University and a PhD degree in tissue engineering from the Institute of General Pathology and Pathophysiology in Moscow.